Increased relative risk for adverse events seen among those admitted during weeks with high versus low COVID-19 burden ...
SGLT2 inhibitors may help reduce the risk of nephrolithiasis in patients with type 2 diabetes, including those with co-existing gout. Recent large-scale studies support that sodium-glucose ...
35% lower risk for diabetes, 20% reduced risk for hypertension seen for sugar restriction in first 3 years after conception ...
Supply chain issues are more likely to result in drug shortages in the United States than in Canada, data suggest.